SCLX - Scilex Holding Co

0.2468
-0.002   -0.689%

Share volume: 894,707
Last Updated: 04-08-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.07%

PREVIOUS CLOSE
CHG
CHG%
$0.25
0.00
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
38%
Profitability 43%
Dept financing 43%
Liquidity 6%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-4.38%
1 Month
-29.49%
3 Months
-45.71%
6 Months
-69.83%
1 Year
-81.85%
2 Year
-98.26%
Key data
Stock price
$0.25
P/E Ratio 
0.00
DAY RANGE
$0.23 - $0.26
EPS 
-$0.34
52 WEEK RANGE
$0.21 - $2.30
52 WEEK CHANGE
-$81.58
MARKET CAP 
177.330 M
YIELD 
N/A
SHARES OUTSTANDING 
191.791 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-15-2025
BETA 
2.85
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,420,119
AVERAGE 30 VOLUME 
$1,154,100
Company detail
CEO: Jaisim Shah
Region: US
Website: scilexholding.com
Employees: 80
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Vickers Vantage Corp. I does not have significant operations. The company was incorporated in 2020 and is based in Singapore. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or reorganization.

Recent news
loading